{
    "clinical_study": {
        "@rank": "14790", 
        "acronym": "PRO-MH2", 
        "arm_group": [
            {
                "arm_group_label": "Patients", 
                "arm_group_type": "Other", 
                "description": "31-Phosphorus RMN Spectroscopy"
            }, 
            {
                "arm_group_label": "Volunteers", 
                "arm_group_type": "Other", 
                "description": "31-Phosphorus RMN Spectroscopy"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this project is to study brain energy profile evolution at different stages\n      of the Huntington disease."
        }, 
        "brief_title": "Utilization of 31P-Nuclear Magnetic Resonance Spectroscopy to Monitor Brain Energy Deficit in Huntington Disease", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Huntington Disease", 
        "condition_browse": {
            "mesh_term": "Huntington Disease"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  UHDRS < 50\n\n          -  Age > 18 years\n\n          -  Ability to undergo MR scanning\n\n          -  Covered by french social security\n\n        Exclusion Criteria:\n\n          -  Evidence of psychiatric disorder\n\n          -  Attendant neurological disorder\n\n          -  Contraindications to MRI (claustrophobia, metallic or material implants)\n\n          -  Severe head injury\n\n          -  Unable to understand the protocol\n\n          -  Pregnancy\n\n          -  Failure to give informed consent\n\n          -  Subjects with exclusion criteria required by french law (e.g. subjects who require a\n             legally authorized representative to obtain consent)\n\n          -  Unwillingness to be informed in case of abnormal MRI"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 20, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01696708", 
            "org_study_id": "C12-49", 
            "secondary_id": "2012-A01063-40"
        }, 
        "intervention": {
            "arm_group_label": [
                "Patients", 
                "Volunteers"
            ], 
            "intervention_name": "31-Phosphorus RMN Spectroscopy", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "June 7, 2013", 
        "location": {
            "contact": {
                "email": "daisy.rinaldi@icm-institute.org", 
                "last_name": "Daisy Rinaldi, PhD"
            }, 
            "facility": {
                "address": {
                    "city": "Paris", 
                    "country": "France", 
                    "zip": "75013"
                }, 
                "name": "Brain and Spine Institute (ICM)"
            }, 
            "investigator": [
                {
                    "last_name": "Perrine Charles, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Alexandra Durr, MD", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "2", 
        "official_title": "Study of the Brain Energy Profile Evolution, Using 31Phosphorus-Nuclear Magnetic Resonance Spectroscopy, at Different Stages of Huntington Disease", 
        "overall_contact": {
            "email": "daisy.rinaldi@icm-institute.org", 
            "last_name": "Daisy Rinaldi, PhD", 
            "phone": "+33 1 57 27 46 78"
        }, 
        "overall_official": {
            "affiliation": "INSERM UMR S975 Institut du Cerveau et de la Moelle, AP-HP D\u00e9partement de G\u00e9n\u00e9tique, Universit\u00e9 Pierre et Marie Curie, Paris France", 
            "last_name": "Fanny Mochel, MD, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "France: Committee for the Protection of Personnes", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "31P-MRS allows quantification of high-energy phosphate metabolites such as phosphocreatine and inorganic phosphate", 
            "measure": "Ratio of Inorganic Phosphate (Pi) over phosphocreatine (PCr): Pi/PCr", 
            "safety_issue": "No", 
            "time_frame": "2 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01696708"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Correlating a brain energy deficit with clinical parameters in Huntington patients such as the Unified Huntington's disease rating scale (UHDRS) and total functional capacity score (TFC).", 
                "measure": "Correlation between primary outcome measure and clinical parameters", 
                "safety_issue": "No", 
                "time_frame": "2 years"
            }, 
            {
                "description": "Patients will be retested after one month.", 
                "measure": "Study of longitudinal changes in Pi/PCr ratio over time.", 
                "safety_issue": "No", 
                "time_frame": "2 years"
            }
        ], 
        "source": "Institut National de la Sant\u00e9 Et de la Recherche M\u00e9dicale, France", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Institut National de la Sant\u00e9 Et de la Recherche M\u00e9dicale, France", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2012", 
        "study_design": "Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "September 2012"
    }
}